DigiPall: digital symptom and wearable monitoring in palliative care
Official title: DigiPall; a Randomized Controlled Trial of Digital Patient Reported Outcome and Biomarker Monitoring in Palliative Care
Run by University of Zurich · NCT06615349 · Data updated 2026-11-12
This project will test whether a wearable that tracks heart rate and steps plus a daily smartphone chatbot that asks about symptoms and gives tips can reduce unplanned hospital readmissions and improve well‑being for people with advanced cancer or other life‑threatening illnesses in palliative care.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 382 (estimated) |
| Sponsor | University of Zurich Academic / other |
| Locations | 1 site (Zurich, Canton of Zurich) |
| Status | Recruiting |
| Started | June 11, 2025 |
| Main results expected | June 2027 |
| Study ends | September 2027 |
| Registry record updated | July 10, 2025 |
| Trial ID | NCT06615349 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal participants are adults with metastatic cancer or other severe life‑threatening illnesses in palliative care, with an estimated life expectancy of roughly 3 to 24 months, adequate functional status (Karnofsky ≥50%/ECOG ≤2), and regular smartphone use.
✕Probably not a fit
Patients receiving curative-intent treatment, those with significant cognitive impairment, without smartphone access, or with very limited life expectancy (under about three months) are unlikely to benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The DigiPall approach combines a wrist-worn device that continuously records heart rate and steps with a smartphone chatbot that prompts daily patient-reported outcome questions and offers self-management tips. Adults receiving palliative care for advanced cancer or other severe illnesses who own a smartphone and meet basic functional criteria are enrolled and remotely monitored. Clinical teams access symptom reports and digital biomarker data to inform outpatient follow-up, with primary outcomes including unplanned hospital readmissions, quality of life, and sense of security. The trial is run at University Hospital Zurich with baseline visits and ongoing remote monitoring.
Why it matters
Potential benefit: If successful, the system could reduce avoidable unplanned hospital readmissions, improve symptom control and quality of life, and increase patients' and caregivers' sense of security at home.
How similar studies have gone: Some prior oncology studies using remote patient-reported outcome monitoring have reduced emergency visits or readmissions, but combining continuous wearable biomarker tracking and chatbot-based daily PROMs specifically in palliative care is relatively novel and evidence is limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with established diagnosis of a metastatic cancer/severe illness with limited life expectancy receiving palliative care services * Estimated life expectancy \<24 months (physician's guess)/ \>3 months * Karnofsky Index ≥ 50% / ECOG≤ 2 * Aged \>18 years * Owns and uses a smartphone * Give written informed consent Exclusion Criteria: * Patients under curative treatment * Relevant cognitive impairment
Where it's running
-
University Hospital Zurich
Zurich, Canton of Zurich, Switzerland Recruiting
Study contacts
- Principal investigator: David Blum, MD PhD — University of Zurich
- Study coordinator: David Blum, MD PhD
- Email: david.blum@usz.ch
- Phone: 0041432533742
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Comparing live music therapy to recorded music therapy for terminally ill patients
This study is testing whether live music therapy can help terminally ill patients feel better compared to listening to recorded music.
-
Empowering Monterey Bay Residents for Collaborative and Equitable Care
This study tests whether regular phone coaching from a trained research assistant helps low-income and minority patients make shared decisions with their clinicians and feel more activated in their care.
-
Wearable ECG patch monitoring for people receiving end-of-life cancer care
This tests whether a small wearable ECG patch can remotely track vital signs for people with advanced cancer in hospice to help spot infections, relate symptoms to physiology, and improve estimates of how long someone may have to live.
-
Removing more mesentery during ileocecal surgery for Crohn's disease
This will test whether removing more of the mesentery during ileocecal surgery lowers the chance Crohn's disease comes back at the bowel connection.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.